GH secretagogues affect bone through both GH-mediated systemic effects and direct skeletal cell actions via ghrelin receptors on osteoblasts — dual mechanism supporting bone health applications.
Key findingGH-releasing peptides affect bone metabolism through both indirect GH/IGF-1 stimulation and direct ghrelin receptor activation on osteoblasts, promoti
What the researchers found
GH-releasing peptides affect bone metabolism through both indirect GH/IGF-1 stimulation and direct ghrelin receptor activation on osteoblasts, promoting bone formation through dual systemic and local mechanisms for potential osteoporosis therapy.
Why it matters
Relevant for ghrp, bone-joint, hormone-optimization, receptor-signaling.
How the study worked
review study on ghrp, bone-joint.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
GH-releasing peptides and bone.
Journal of endocrinological investigation, 28(8 Suppl), 11-4
Citation
Cocchi, D; Maccarinelli, G; Sibilia, V; Tulipano, G; Torsello, A; Pazzaglia, U E; Giustina, A; Netti, C. (2005). GH-releasing peptides and bone.. Journal of endocrinological investigation, 28(8 Suppl), 11-4.